📣 VC round data is live. Check it out!
- Public Comps
- Daesang Holdings
Daesang Holdings Valuation Multiples
Discover revenue and EBITDA valuation multiples for Daesang Holdings and similar public comparables like Cartavio, Limoneira, Manner, Treatt and more.
Daesang Holdings Overview
About Daesang Holdings
Daesang Holdings Co Ltd is a holding company. The company is engaged in the manufacturing and sale of processed food products such as processed food and starch products. Its products mostly include Soyabean paste; Marinade; Soy sauce; fish sauce and amongst others.
Founded
2005
HQ

Employees
N/A
Website
Financials (FY)
EV
$1B
Valuation Multiples
Start free trialDaesang Holdings Financials
Daesang Holdings reported last fiscal year revenue of $4B and EBITDA of $15M.
In the same fiscal year, Daesang Holdings generated $1B in gross profit, $15M in EBITDA, and had net loss of ($73M).
Daesang Holdings P&L
In the most recent fiscal year, Daesang Holdings reported revenue of $4B and EBITDA of $15M.
Daesang Holdings is unprofitable as of last fiscal year, with gross margin of 26%, EBITDA margin of 0%, and net margin of (2%).
Financial data powered by Morningstar, Inc.
Daesang Holdings Stock Performance
Daesang Holdings has current market cap of $235M, and enterprise value of $1B.
Daesang Holdings' stock price is $6.33.
Daesang Holdings has an EPS (earnings per share) of $-1.97.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $235M | -0.4% | — | — | — | $-1.97 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDaesang Holdings Valuation Multiples
Daesang Holdings trades at 0.3x EV/Revenue multiple, and 66.7x EV/EBITDA.
Daesang Holdings Financial Valuation Multiples
As of May 10, 2026, Daesang Holdings has market cap of $235M and EV of $1B.
Daesang Holdings has a P/E ratio of (3.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Daesang Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Daesang Holdings Margins & Growth Rates
In the most recent fiscal year, Daesang Holdings reported gross margin of 26%, EBITDA margin of 0%, and net margin of (2%).
Daesang Holdings Margins
Daesang Holdings Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Daesang Holdings Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Daesang Holdings Competitors
Daesang Holdings competitors include Cartavio, Limoneira, Manner, Treatt, Accel, Easy Holdings Co, CJ Freshway, Fine Foods, ADM Hamburg and EVI Industries.
Most Daesang Holdings public comparables operate across Food & Beverages and Business Services.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | — | — | |||
| 2.1x | 2.3x | (51.7x) | 1154.3x | |||
| 0.7x | — | 8.6x | — | |||
| 1.4x | 1.4x | 11.3x | 11.0x | |||
| 0.8x | — | 5.2x | — | |||
| 0.3x | — | 4.3x | — | |||
| 0.2x | 0.2x | 3.9x | 3.8x | |||
| 1.0x | 1.0x | 7.0x | 6.6x | |||
This data is available for Pro users. Sign up to see all Daesang Holdings competitors and their valuation data. Start Free Trial | ||||||
Daesang Holdings Investment Activity
Daesang Holdings has invested in 1 company to date.
Latest investment by Daesang Holdings was on December 19th 2023. Daesang Holdings invested in Amtix Bio in their $6M Strategic investment round (EV/Revenue multiple of ).
Latest Investments by Daesang Holdings
| Description | Amtix Bio is a biotechnology firm developing antimicrobial peptides and small molecules targeting bacterial infections and related conditions like sepsis. Based in Israel, the company advances candidates through preclinical stages for gram-positive and gram-negative pathogens. |
| HQ Country | |
| HQ City | Seoul |
| Deal Date | 19 Dec 2023 |
| Round | Strategic investment |
| Raised | $6M |
| Investors | Daesang Holdings |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Daesang Holdings investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Daesang Holdings
| When was Daesang Holdings founded? | Daesang Holdings was founded in 2005. |
| Where is Daesang Holdings headquartered? | Daesang Holdings is headquartered in South Korea. |
| Is Daesang Holdings publicly listed? | Yes, Daesang Holdings is a public company listed on Korea Exchange. |
| What is the stock symbol of Daesang Holdings? | Daesang Holdings trades under 084690 ticker. |
| When did Daesang Holdings go public? | Daesang Holdings went public in 2005. |
| Who are competitors of Daesang Holdings? | Daesang Holdings main competitors include Cartavio, Limoneira, Manner, Treatt, Accel, Easy Holdings Co, CJ Freshway, Fine Foods, ADM Hamburg, EVI Industries. |
| What is the current market cap of Daesang Holdings? | Daesang Holdings' current market cap is $235M. |
| What is the current revenue of Daesang Holdings? | Daesang Holdings' last fiscal year revenue is $4B. |
| What is the current EV/Revenue multiple of Daesang Holdings? | Current revenue multiple of Daesang Holdings is 0.3x. |
| Is Daesang Holdings profitable? | No, Daesang Holdings is not profitable. |
| How many companies Daesang Holdings has acquired to date? | Daesang Holdings hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Daesang Holdings has invested to date? | As of May 2026, Daesang Holdings has invested in 1 company. |
| What was the last Daesang Holdings investment? | On 19th December 2023 Daesang Holdings invested in Amtix Bio, participating in a $6M Strategic investment round. |
| In what companies Daesang Holdings invested in? | Daesang Holdings invested in Amtix Bio. |
See public comps similar to Daesang Holdings
Lists including Daesang Holdings
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
